G-CSF for stem cell therapy in acute myocardial infarction: Friend or foe?

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 20-30

  Shim, Winston ^a   Mehta, Ashish ^a   Lim, Sze Yun ^a   Zhang, Guangqin ^a   Lim, Chong Hee ^a   Chua, Terrance ^a   Wong, Philip ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Cardiac repair; CXCR4; G CSF; Ischaemia; Myocardial infarction; Stem cell therapy

Indexed keywords

CD34 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; CYCLOOXYGENASE 2; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; RAPAMYCIN; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ACUTE HEART INFARCTION; AGING; ANGIOCARDIOGRAPHY; APOPTOSIS; BARE METAL STENT; CARDIOVASCULAR RISK; CELL HOMING; CELL PROLIFERATION; CELL REGENERATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG ELUTING STENT; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WORK; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMODULATION; IN-STENT RESTENOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VASCULAR SMOOTH MUSCLE;

ADULT STEM CELLS; ANIMALS; CLINICAL TRIALS AS TOPIC; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; JANUS KINASES; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VENTRICULAR REMODELING;

EID: 78650460832     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq301     Document Type: Review

References (120)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117: e25-e146.
2. Takano H, Ueda K, Hasegawa H, Komuro I. G-CSF therapy for acute myocardial infarction. Trends Pharmacol Sci 2007;28:512-517.
3. Kuethe F, Krack A, Fritzenwanger M, Herzau M, Opfermann T, Pachmann K et al. Treatment with granulocyte-colony stimulating factor in patients with acute myocar-dial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion. Pharmazie 2006;61:957-961.
4. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002;298: 2188-2190.
5. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004;364:183-192.
6. Menasche P. [Cell therapy for heart failure]. Bull Mem Acad R Med Belg 2003;158: 409-420; discussion 421-403.
7. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005;11:305-311.
8. Ohtsuka M, Takano H, Zou Y, Toko H, Akazawa H, Qin Y et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004;18:851-853.
9. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-10349.
10. Rankin SM. Impact of bone marrow on respiratory disease. Curr Opin Pharmacol 2008;8:236-241.
11. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438. (Pubitemid 29180584)
12. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neo-vascularization. Genes Dev 2007;21:1546-1558.
13. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multiline-age potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
14. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009;4: 62-72.
15. Cashen AF, Link D, Devine S, DiPersio J. Cytokines and stem cell mobilization for autologous and allogeneic transplantation. Curr Hematol Rep 2004;3:406-412.
16. Shimoji K, Yuasa S, Onizuka T, Hattori F, Tanaka T, Hara M et al. G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 2010;6:227-237.
17. Ott HC, Taylor DA. From cardiac repair to cardiac regeneration - ready to translate? Expert Opin Biol Ther 2006;6:867-878.
18. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 2006;20:956-958.
19. Okada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T et al. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure. Am J Physiol Heart Circ Physiol 2009;296: H616-H626.
20. Hiraumi Y, Iwai-Kanai E, Baba S, Yui Y, Kamitsuji Y, Mizushima Y et al. Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury. Am J Physiol Heart Circ Physiol 2009;296:H823-H832.
21. Takano H, Qin Y, Hasegawa H, Ueda K, Niitsuma Y, Ohtsuka M et al. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med 2006;84:185-193.
22. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulo-cyte colony-stimulating factor treatment. Circulation 2004;109:2572-2580.
23. Li Y, Takemura G, Okada H, Miyata S, Esaki M, Maruyama R et al. Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Lab Invest 2006;86:32-44.
24. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779.
25. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005;26:1196-1204.
26. Ince H, Petzsch M, Kleine HD, Schmidt H, Rehders T, Korber T et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005;112: 3097-3106.
27. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006;295:1003-1010.
28. Meenhuis A, Irandoust M, Wolfler A, Roovers O, Valkhof M, Touw IP. Janus kinases promote cell-surface expression and provoke autonomous signalling from routing-defective G-CSF receptors. Biochem J 2009;417:737-746.
29. Kurdi M, Booz GW. G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery. Congest Heart Fail 2007;13: 221-227.
30. Kurdi M, Booz GW. JAK redux: a second look at the regulation and role of JAKs in the heart. Am J Physiol Heart Circ Physiol 2009;297:H1545-H1556.
31. Ueda K, Takano H, Hasegawa H, Niitsuma Y, Qin Y, Ohtsuka M et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol 2006; 26:e108-e113.
32. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;61:402-413.
33. Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci USA 2004;101:3136-3141.
34. Carrao AC, Chilian WM, Yun J, Kolz C, Rocic P, Lehmann K et al. Stimulation of coronary collateral growth by granulocyte stimulating factor: role of reactive oxygen species. Arterioscler Thromb Vasc Biol 2009;29:1817-1822.
35. Broxmeyer HE. Chemokines in hematopoiesis. Curr Opin Hematol 2008;15:49-58.
36. Noseda M, Schneider MD. Previews. Unleashing cardiopoiesis: a novel role for G-CSF. Cell Stem Cell 2010;6:188-189.
37. Zhang Z, Zhong W, Hall MJ, Kurre P, Spencer D, Skinner A et al. CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis. Exp Eye Res 2009;89:522-531.
38. Chen J, Chemaly E, Liang L, Kho C, Lee A, Park J et al. Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. Am J Pathol 2010;176: 1705-1715.
39. Cho KA, Ju SY, Ryu KH, Woo SY. Hypoxia affected SDF-1alpha-CXCR4 interaction between bone marrow stem cells and osteoblasts via osteoclast modulation. Acta Haematol 2010;123:43-47.
40. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-694.
41. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005;15:57-63.
42. Zaruba MM, Franz WM. Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opin Biol Ther 2010;10:321-335.
43. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M et al. Effect of stromal-cell-derived factor1 on stem-cell homing and tissue regeneration in ischae-mic cardiomyopathy. Lancet 2003;362:697-703.
44. Christopherson KW 2nd, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/ DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003;101: 4680-4686.
45. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006;20:1915-1924.
46. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864.
47. Wei HM, Wong P, Hsu LF, Shim W. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. Singapore Med J 2009;50:935-942.
48. Engelmann MG, Franz WM. Stem cell therapy after myocardial infarction: ready for clinical application? Curr Opin Mol Ther 2006;8:396-414.
49. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006;27:2775-2783.
50. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T et al. Intracor-onary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209.
51. Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006;48:1712-1721.
52. Lehrke S, Mazhari R, Durand DJ, Zheng M, Bedja D, Zimmet JM et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 2006;99:553-560.
53. Reed MJ, Edelberg JM. Impaired angiogenesis in the aged. Sci Aging Knowledge Environ 2004;2004:pe7.
54. Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004;94:514-524.
55. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003;93:604-613.
56. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S et al. Apop-totic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
57. Azhar G, Gao W, Liu L, Wei JY. Ischemia-reperfusion in the adult mouse heart influence of age. Exp Gerontol 1999;34:699-714.
58. Martin I, Grotewiel MS. Oxidative damage and age-related functional declines. Mech Ageing Dev 2006;127:411-423.
59. Ballard VL, Edelberg JM. Stem cells and the regeneration of the aging cardiovascular system. Circ Res 2007;100:1116-1127.
60. Anderlini P, Przepiorka D, Lauppe J, Seong D, Giralt S, Champlin R et al. Collection of peripheral blood stem cells from normal donors 60years of age or older. Br J Hae-matol 1997;97:485-487. (Pubitemid 27224636)
61. Overgaard M, Ripa RS, Wang Y, Jørgensen E, Kastrup J. Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial. Int J Cardiol 2009;140:351-355.
62. Engelmann MG, Theiss HD, Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE et al. G-CSF in patients suffering from late revascularized ST elevation myocardial infarction: analysis on the timing of G-CSF administration. Exp Hematol 2008;36:703-709.
63. Beohar N, Flaherty JD, Davidson CJ, Vidovich M, Singhal S, Rapp JA et al. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing. Catheter Cardiovasc Interv 2007;69:257-266.
64. Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sorensen M et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006;92:768-774.
65. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, Fabritz L et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased con-nexin43 expression and arteriogenesis. J Exp Med 2006;203:87-97.
66. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221. (Pubitemid 44427445)
67. Boyle AJ, Whitbourn R, Schlicht S, Krum H, Kocher A, Nandurkar H et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 2006;109:21-27.
68. Leone AM, Galiuto L, Garramone B, Rutella S, Giannico MB, Brugaletta S et al. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA study). Am J Cardiol 2007;100:397-403.
69. Suarez de Lezo J, Torres A, Herrera I, Pan M, Romero M, Pavlovic D et al. [Effects of stem-cell mobilization with recombinant human granulocyte colony stimulating factor in patients with percutaneously revascularized acute anterior myocardial infarction]. Rev Esp Cardiol 2005;58:253-261.
70. Forest VF, Tirouvanziam AM, Perigaud C, Fernandes S, Fusellier MS, Desfontis JC et al. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Res Ther 2010;1:4.
71. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005;112: I150-I156.
72. Mesquita CT, Correa PL, Felix RC, Azevedo JC, Alves S, Oliveira CC et al. Auto-logous bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary stem cell therapy in acute myocardial infarction. J Nucl Cardiol 2005;12:610-612.
73. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-2202.
74. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008;102:1319-1330.
75. Assmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J et al. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. J Am Coll Cardiol 2010;55:1385-1394.
76. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363: 751-756.
77. Ince H, Nienaber CA. Future investigations in stem cell activation with granulocyte-colony-stimulating factor after myocardial infarction. Nat Clin Pract Car-diovasc Med 2007;4 Suppl 1:S119-S122.
78. Bayes-Genis A, Salido M, Sole Ristol F, Puig M, Brossa V, Camprecios M et al. Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc Res 2002; 56:404-410.
79. Fukuda S, Yoshii S, Kaga S, Matsumoto M, Kugiyama K, Maulik N. Angiogenic strategy for human ischemic heart disease: brief overview. Mol Cell Biochem 2004;264: 143-149.
80. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004;110:2039-2046.
81. Takamiya M, Okigaki M, Jin D, Takai S, Nozawa Y, Adachi Y et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arter-ioscler Thromb Vasc Biol 2006;26:751-757.
82. Falanga A, Marchetti M, Evangelista V, Manarini S, Oldani E, Giovanelli S et al. Neu-trophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 1999;93:2506-2514.
83. Valgimigli M, Rigolin GM, Cittanti C, Malagutti P, Curello S, Percoco G et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 2005;26:1838-1845.
84. Steinwender C, Hofmann R, Kypta A, Kammler J, Kerschner K, Grund M et al. In-stent restenosis in bare metal stents versus sirolimus-eluting stents after primary coronary intervention for acute myocardial infarction and subsequent trans-coronary transplantation of autologous stem cells. Clin Cardiol 2008;31:356-359.
85. Steinwender C, Hofmann R, Kammler J, Kypta A, Pichler R, Maschek W et al. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction. Am Heart J 2006;151:1296 e7-1296 e13.
86. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355: 1093-1104.
87. Cho HJ, Kim TY, Cho HJ, Park KW, Zhang SY, Kim JH et al. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. J Am Coll Cardiol 2006;48:366-374.
88. Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114:I145-I151.
89. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004;63:617-624.
90. Aoki J, Abizaid AC, Ong AT, Tsuchida K, Serruys PW. Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist? EuroIntervention 2005;1:235-255.
91. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G et al. Endo-thelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005;45:1574-1579.
92. Co M, Tay E, Lee CH, Poh KK, Low A, Lim J et al. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J 2008;155:128-132.
93. Klomp M, Beijk MA, de Winter RJ. Genous endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Rev Med Devices 2009;6:365-375.
94. Lee YP, Tay E, Lee CH, Low A, Teo SG, Poh KK et al. Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one year follow-up. EuroIntervention 2010;5:698-702.
95. Nakazawa G, Granada JF, Alviar CL, Tellez A, Kaluza GL, Guilhermier MY et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2010;3:68-75.
96. Ince H, Valgimigli M, Petzsch M, de Lezo JS, Kuethe F, Dunkelmann S et al. Cardiovascular events and re-stenosis following administration of G-CSF in acute myocar-dial infarction: systematic review and meta-analysis. Heart 2008;94:610-616.
97. Fan L, Chen L, Chen X, Fu F. A meta-analysis of stem cell mobilization by granulo-cyte colony-stimulating factor in the treatment of acute myocardial infarction. Cardiovasc Drugs Ther 2008;22:45-54.
98. Zohlnhofer D, Dibra A, Koppara T, de Waha A, Ripa RS, Kastrup J et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J Am Coll Cardiol 2008;51:1429-1437.
99. Kang S, Yang Y, Li CJ, Gao R. Effectiveness and tolerability of administration of gra-nulocyte colony-stimulating factor on left ventricular function in patients with myo-cardial infarction: a meta-analysis of randomized controlled trials. Clin Ther 2007;29: 2406-2418.
100. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences in myo-cardial remodeling. J Am Coll Cardiol 2010;55:1057-1065.
101. Mallat Z, Fornes P, Costagliola R, Esposito B, Belmin J, Lecomte D et al. Age and gender effects on cardiomyocyte apoptosis in the normal human heart. J Gerontol A Biol Sci Med Sci 2001;56:M719-M723.
102. Zhang XP, Vatner SF, Shen YT, Rossi F, Tian Y, Peppas A et al. Increased apoptosis and myocyte enlargement with decreased cardiac mass; distinctive features of the aging male, but not female, monkey heart. J Mol Cell Cardiol 2007;43:487-491.
103. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995; 26:1068-1079.
104. Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation 2007;116:2747-2759.
105. Wang Y, Zheng N, Lu Z, Wu W, Wang L, Nakao A et al. In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulation. Liver Transpl 2006;12:1850-1861.
106. Shim WS, Jiang S, Wong P, Tan J, Chua YL, Tan YS et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 2004;324:481-488.
107. Tan G, Shim W, Gu Y, Qian L, Chung YY, Lim SY et al. Differential effect of myo-cardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells. Differentiation 2010;79:260-271.
108. Shim WS, Tan G, Gu Y, Qian L, Li S, Chyng YY et al. Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function. J Heart Lung Trans 2010; doi:10.1016/j.healun.2010.06.009. Published online ahead of print 4 August 2010.
109. Spadaccio C, Chachques E, Chello M, Covino E, Chachques JC, Genovese J. Pre-differentiated adult stem cells and matrices for cardiac cell therapy. Asian Cardiovasc Thorac Ann 2010;18:79-87.
110. Ellis SG, Penn MS, Bolwell B, Garcia M, Chacko M, Wang T et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am Heart J 2006;152:1051 e9-1051 e14.
111. Ripa RS, Jørgensen E, Wang Y, Thune JJ, Nilsson JC, Søndergaard L et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006;113:1983-1992.
112. Wang Y, Tagil K, Ripa RS, Nilsson JC, Carstensen S, Jorgensen E et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005;100:477-483.
113. Deng Z, Yang C, Deng H, Yang A, Geng T, Chen X et al. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction. Int J Cardiol 2006;113:92-96.
114. Zbinden S, Zbinden R, Meier P, Windecker S, Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005; 46:1636-1642.
115. Malafronte C, Achilli F. Stem cells mobilization in acute myocardial infarction (stem-AMI trial): preliminary data of a perspective, randomized, single blind trial. Minerva Cardioangiol 2007;55:721-731.
116. Kang HJ, Kim HS, Koo BK, Kim YJ, Lee D, Sohn DW et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 2007;153:237 e1-237 e8.
117. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phaseI/IIa double-blind, randomized controlled trial. Circulation 2007;115: 3165-3172.
118. Yaoita H, Takase S, Maruyama Y, Sato Y, Satokawa H, Hoshi N et al. Scintigraphic assessment of the effects of bone marrow-derived mononuclear cell transplantation combined with off-pump coronary artery bypass surgery in patients with ischemic heart disease. J Nucl Med 2005;46:1610-1617.
119. Kovacic JC, Macdonald P, Feneley MP, Muller DW, Freund J, Dodds A et al. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Am Heart J 2008;156:954-963.
120. Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, Kastrup J. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J 2006;27:1785-1792.